Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)
A legfontosabb adatok
- Ki végzi
- Fondation Ophtalmologique Adolphe de Rothschild
- Hol
- Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 50 fő, tervezett
- Kezdés
- 2023. nov. 28.
- Várható befejezés
- 2027. ápr.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Injected cerebral MRI angiography and ultrasound of the superior aortic trunks, temporal and axillary arteries
- A regiszteradat frissítve
- 2024. június 4.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for people aged 50 and over with giant cell arteritis (Horton's disease), diagnosed with MRI and ultrasound. Scans are repeated over time to see how the arteries change during treatment.
- Életkor
- 50 years and over
- Nem
- All sexes
- A betegség stádiuma
- Giant cell arteritis according to ACR/EULAR 2022 criteria, diagnosed with MRI and ultrasound
A részvétel fő kizáró okai
- Cannot have an MRI scan, for example due to an incompatible implanted device or fear of closed spaces (claustrophobia)
- Allergy to gadobutrol, the MRI contrast dye
- Under legal protection
- Pregnant or breast-feeding women
A regiszter feltételei, szó szerint
Mind a 9 feltétel megnézéseKevesebb
Ki vehet részt
- Patient aged 50 and over
- Having received informed consent to participate in the study
- Affiliated or beneficiary of a social insurance scheme
- Patients with giant cell arteritis according to ACR/EULAR 2022 criteria
- Diagnosed with MRI and ultrasound
Ki nem vehet részt
- Hypersensitivity to gadobutrol
- Absolute or relative contraindication to MRI (incompatible implantable device, claustrophobia, etc.)
- Patient under legal protection
- Pregnant or breast-feeding women
Ez a vizsgálat jelenleg itt érhető el: Franciaország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Giant cell arteritis (GCA), also known as Horton's disease, is an inflammatory arteritis of the large and medium-sized arteries, with an estimated incidence of 17.8/100,000 in people over 50.
A teljes eredeti leírásKevesebb
The disease presents potential ophthalmological, neurological, cardiac and aortic vascular complications, making diagnosis an emergency in cases of suspected Horton's disease.
only corticosteroid therapy started as early as possible can prevent these complications.
Diagnosis has historically relied on temporal artery biopsy, but the recent ACR/EULAR 2022 classification criteria propose alternatives to this invasive examination, in particular imaging tests such as temporal artery ultrasound and PET scans. Although not included in these latest recommendations, high-definition wall MRI can also provide arguments in favor of this diagnosis, and avoid the need for a temporal artery biopsy, the sensitivity of which is only 75%. The investigators recently demonstrated in a prospective cohort that wall MRI, possibly coupled with temporal artery ultrasound or retinal angiography, was far superior to temporal artery biopsy in diagnostic performance.
The main limitation of these imaging tests is the lack of data in the literature on the evolution of abnormalities over time, and in particular after initiation of oral corticosteroid therapy. This uncertainty makes it difficult to use these examinations to monitor disease activity, particularly in cases of suspected relapse, a frequent situation in which the clinician is regularly put at fault due to an often frustrating symptomatology and the possible absence of a frank biological inflammatory syndrome.
The investigators propose to conduct a study aimed at describing the evolution of cranial vessel wall abnormalities on wall MRI and ultrasound by systematically repeating these examinations at 1 month, 3 months from the initial MRI performed at diagnosis, in addition to the follow-up performed as part of care at 6 and 12 months from diagnosis. In the event of a relapse in the intervening period, a new MRI scan can be performed and compared with the most recent MRI scan, to look for evidence of disease activity.
A vizsgált kezelések
- Injected cerebral MRI angiography and ultrasound of the superior aortic trunks, temporal and axillary arteries
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis)
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
- A regiszteradat frissítve
- 2024. június 4.